Immunogen reported $373.87M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Amgen AMGN:US $ 5203M 1325M
Astellas Pharma 4503:JP Y 313013M 2973M
AstraZeneca AZN:LN 395649.11M 43092.62M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Emergent Biosolutions EBS:US $ 358.1M 77.7M
Exelixis EXEL:US $ 627M 96.27M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Immunogen IMGN:US $ 373.87M 63.79M
Intrexon XON:US $ 43.84M 3.52M
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Macrogenics MGNX:US $ 21.47M 25.86M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Novartis NVS:US $ 3625M 10227M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Seattle Genetics SGEN:US $ 364.87M 103.88M